Pregnant women who are overweight or obese are at least 10 times more likely than women of normal weight to have their fetal ultrasound screening recalled due to poor results, according to Canadian researchers.
Pregnant women who are overweight or obese are at least 10 times more likely than women of normal weight to have their fetal ultrasound screening recalled due to poor results, according to Canadian researchers.
Dr. Phyllis Glanc and colleagues at the University of Toronto assessed 100 women with a body mass index >30 who underwent routine second trimester fetal anatomic survey. They matched each case with two control subjects of normal weight and similar gestational age. They found 72% of pregnant women with high BMI had incomplete or unsatisfactory exams and about 26% required additional ultrasound scans to complete their surveys versus 2.5% of controls. Almost two-thirds of recalled exams remained categorized as having suboptimal visualization. Glanc presented the study at the 2008 ARRS meeting.
FDA Clears AI-Powered Ultrasound Software for Cardiac Amyloidosis Detection
November 20th 2024The AI-enabled EchoGo® Amyloidosis software for echocardiography has reportedly demonstrated an 84.5 percent sensitivity rate for diagnosing cardiac amyloidosis in heart failure patients 65 years of age and older.
Ultrasound Device Garners FDA De Novo Nod for Kidney Stone Clearance
November 14th 2024Emerging research demonstrated that the Stone Clear device, which facilitates post-lithotripsy clearance of kidney stone fragments, led to a 70 percent lower risk of relapse in comparison to observation in a control group.